Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
The Journal of Infectious Diseases|April 9, 2019
Immunogenicity and Safety of a Sabin Strain-Based Inactivated Polio Vaccine: A Phase 3 Clinical TrialYuemei Hu, Jianfeng Wang, Gang Zeng, et al.
Food Research International (Ottawa, Ont.)|September 14, 2024
Modulation of acid-induced pea protein gels by gellan gum and glucono-δ-lactone: Rheological and microstructural insightsChanghong Li, Taotao Dai, Deyu Jiang, et al.
Open Forum Infectious Diseases|October 30, 2019
Safety and Immunogenicity of Sabin Strain Inactivated Poliovirus Vaccine Compared With Salk Strain Inactivated Poliovirus Vaccine, in Different Sequential Schedules With Bivalent Oral Poliovirus Vaccine: Randomized Controlled Noninferiority Clinical Trials in ChinaYuemei Hu, Kangwei Xu, Weixiao Han, et al.
Bioresource Technology|February 9, 2019
Co-pyrolysis of biomass and soapstock in a downdraft reactor using a novel ZSM-5/SiC composite catalystLin Jiang, Yunpu Wang, Leilei Dai, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 22, 2023
Safety, immunogenicity, and lot-to-lot consistency of a multidose Sabin strain-based inactivated polio vaccine: a phase III, randomized, blinded, positive-control clinical trial in infants aged 2 monthsGuangwei Feng, Deyu Jiang, Weixiao Han, et al.
Vaccines|February 26, 2022
Safety, Immunogenicity and Lot-to-Lot Consistency of Sabin-Strain Inactivated Poliovirus Vaccine in 2-Month-Old Infants: A Double-Blind, Randomized Phase III TrialYan Zheng, Zhifang Ying, Yanxiang Zou, et al.
The Lancet. Infectious Diseases|December 10, 2021
Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trialsGang Zeng, Qianhui Wu, Hongxing Pan, et al.
Science (New York, N.Y.)|May 8, 2020
Development of an inactivated vaccine candidate for SARS-CoV-2Qiang Gao, Linlin Bao, Haiyan Mao, et al.
Pageof 2